Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ICAgen obtains patent and exclusive rights to ion channel technology

Feb. 11, 1999

Dexemel drug delivery vehicle approved in the U.K.

Feb. 10, 1999

Nexell awarded U.S. patent for neutropenia therapy

Feb. 10, 1999

Novel gene delivery system available for licensing from NIH

Feb. 9, 1999

Avigen granted U.S. patent for TVI gene therapy

Feb. 9, 1999

Sch-217048: potent and selective neurokinin antagonist from natural sources

Feb. 8, 1999

Genelabs Technologies' DARPA drug discovery grant renewed

Feb. 8, 1999

AxyS and Protein Design Labs enter drug discovery agreement

Feb. 2, 1999

BioFocus and Pharmacia & Upjohn join forces in drug discovery

Feb. 1, 1999

Abgenix and Genentech form new antibody collaboration

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...